Details
Category: Volume 06 Issue 12 December 2018
Hits: 1405

Title: Haematological Profiles of Women on Some Contraceptives in Selected Family Planning Clinics in Kaduna State, Nigeria

Authors: Egbunah, M. O., Eze, E. M., Ebirien-Agana, B.S., Jeremiah, Z. A

 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.12

Abstract

This study assessed the haematological profile of women of reproductive age on progestogen-only injectable and implant hormonal contraceptives in a selected family planning clinics in Kaduna State. A total of 250 women comprising 150 contraceptive users and100 non-users attending the family planning clinic of Yusuf Dantsoho Memorial Hospital and Primary Health Centre, in Kaduna State of Nigeria participated in this study. Two milliliter of venous blood was collected from each participant using standard venipuncture technique. The samples were analyzed for full blood count using auto analyzer. All standard operating procedures were adhered to. The data obtained was analyzed using R 3.03 software. The Mean±SD lymphocytes(x109/l), lymphocyte(%), granulocyte (%) (2.64±0.79x109/L, 41.41±6.70%, 44.09± 6.57% in these order) for contraceptives users were significantly lower than the control group (2.95± 0.77 x109/L, 48.14 ± 6.38%, 44.83±9.14% in these order)  (P<0.05). The contraceptive users had a greater mean values for MCV and MCH (81.89±6.36fl, 25.40 ± 0.15pg respectively) compared to non-users (79.13±5.70 fl; 24.71± 0.26pg respectively) (p<0.05). Contraceptive users were divided into implant and injectable groups. The implant users showed decreased TWBC:5.66±0.82x109/L, lymphocytes:2.28±0.37x109/L, granulocytes:2.36±0.39x109/L, MCV: 78.44±4.82fl, MCH: 24.23±1.13pg and increased RBC: 5.16 ± 0.66 x 1012/l compared to 6.81±1.90 x109/L, 2.97±0.86 x109/L, 3.08±1.07 x109/L, 83.30±6.37fl, 25.88±1.92pg and 4.88 ± 0.56 X1012/L in these orderfor the injectable users (p<0.05).The use of implants may dampen the immunity of the users and lead to microytic hypochromic anaemia. Baseline evaluation of anaemia in women prior to commencement of hormonal contraceptives is recommended.

Keywords: Haematological profile, contraceptives, women, family, Kaduna, Nigeria.

References

  1. Adejumo, E.N., Adediji, I.O. & Akinmulero, A.O. (2016). Effect of hormonal contraceptives on the total antioxidant status of women from Isolo, Lagos state, Nigeria. Journal of Biosciences and Medicines, 4, 107-111.
  2. Mosher, W.D. & Jones, J. (2010). Use of Contraception in the United States. Vital and Health Statistics, 23, 1982-2008.
  3. Nigeria Demographic Health Survey (2013). Key Findings. 67-69, 72-74.
  4. Blackstone, S.R. & Iwelunmor, J. (2017). Nigerian couples: evidence from the 2013 Demographic and Health Survey. Contraception and Reproductive Medicine, 2, 9-11.
  5. Jacobstein, R. & Polis, C.B. (2014). Progestin-only contraception: Injectables andImplants. Best Practice & Research Clinical Obstetrics and Gynaecology, 28, 795-806.
  6. Mohammed-Durosinlorun, A., Abubakar, A., Adze, J., Bature, S.,  Mohammed, C. & Ojabo, A. (2016). Comparison of contraceptive methods chosen by breastfeeding and non-breastfeeding women at a family planning clinic in northern Nigeria. Health, 8, 191-197.
  7. Croxatt, H.B. (2002). Progestin Implants for Female Contraception. Contraception, 65, 15 – 19.
  8. Meirik, O., Brache, V., Orawan, K. & Ali, M. (2013). A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with non-randomised copper – IUD controls: methodology and insertion data. Contraception, 87, 113 – 120.
  9. Mommers, E. Blum, G.F., Gent, T.G. & Marintchava-Petrova, M. (2012). Nexplanon, a radiopaque etonogestrel implant in combination with a next generation applicator: 3 years results of a non-comparative multicenter trial. American Journal of Obstetrics and Gynaecology, 207(5), 388. l – 6.
  10. Graesslin, O. & Korver, T. (2008). The contraceptive efficacy of implanon: a review of clinical trials and marketing experience. European Journal of contraception and Reproduction Healthcare, 13(1), 4 – 12.
  11. Brogan, K. (2013). Oral Contraceptives: Mind-Body Poison. Alternative and Integrative Medicine, 2, 124.
  12. Hugon-Rodin, J., Gompel, A. & Plu-Bureau, G. (2014). Epidemiology of hormonal contraceptives-related venous thromboembolism. European Journal of Endocrinology, 171, R221–R230.
  13. Afsar, N. A., Barakzai, Q. & Adil, S. N. (2005). Effect of a Progestin only` contraceptive on platelet aggregation in a Pakistani set of population; Journal of Ayub Medical College Abottabad., 17(3), 21-25.
  14. Donald, E. G., Dilip, R. P. & Mary, E.R. (2001). Contraception in the Adolescent: An Update. Pediatrics, 107 (3), 562 – 573.Eliana, I., Mynyr, , and Jurida,  A. (2013).  Effect of a Combined Oral Contraceptive Containing 30 mg Ethinylestradiol and 75 mg Gestodene on Haemostatic Mechanisms in a Group of Albanian Women.  International Conference on Medical, Biological and Pharmaceutical Sciences, 17-18, 271 – 274.
  15. Davis, A.J. (1996). Use of Depot Medioxy progesterone acetate Contraception in adolescents. Journal of Reproductive Medicine, 41, 407 – 413.
  16. Thirup, P. (2003). Haematocrit: Within subject and seasonal variation. Sports Medical Journal, 33, 231-243.
  17. Nakada, D., Oguro, H., Levi, B.P., Ryan, N., Kitano, A. & Saitoh, Y. (2014). Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy. Nature, 505, 556-564.
  18. Sajida, S. H., Al-Chalaby, S.M.T. & Amjad, F.A. (2006). The Effect of Oral Contraceptive Pills on Haematological Indices. Tikrit Medical Journal, 12(1), 65-69.
  19. Toryila, J.E., Amadi, K., Odeh, S.O., Adelaiye, A.B., Egesie, U.G. & Achie, l. N. (2014). Dynamics of Combined Oral Contraceptive: A Study of Some Haematological Parameters in Female Wistar Rats. IOSR Journal of Pharmacy, 4(9), 15-19.
  20. Surasak, T. (2007). Effect of a new oral contraceptive with drospirenone on vital signs, complete blood count, glucose, electrolytes, renal and liver function. Journal of Medical Association of Thailand, 90(3), 426-431.
  21. Okoye, N.F. & Uwakwe , A.A. (2016). Investigation into the effects of oral contraceptives on some haematological parameters of Wistar albino rat Rattus rattus. Scientia Africana, 15(1), 231-235.
  22. Aitazaz, F., Jawed, S., Bhatti, A. & Akbar, A. (2016). Haemoglobin status in reproductive age group women using hormonal contraceptives. Pakistan Journal of Physiology, 12 (1), 10–12.
  23. Aisien AO, Sagay, A.S., Imade, G.E. & Ujah, I.A.O. (2002). Evaluation of menstrual and haematological parameters, after 36 months of Norplant contraception. Journal of Obstetrics and Gynaecology, 22, 406-410.
  24. Chikhale, M. P. (2015). Haematological Changes in wistar Female Albino Rats Fed with Steroidal and Non- Steroidal Contraceptive Pills.International Journal of Pure and Applied Zoology, 3(4), 318-321.
  25. Jamil, S., Rafeeq, A. K., Huma Dilshad & Sakina Fatima (2014). Haematologic Variations Associated With the Long Term Use of Contraceptives in Young Females. American Journal of Phytomedicine and Clinical Therapeutic, 2(5), 580-586.
  26. Peter, U. O. (2013). Women use of oral contraceptives – does it have any effect on haematological parameters? Annals of the College of Medicine, 33(1 & 2), 134-137
  27. Bulur, S., Albayrak, M., Bulur, S., Keskin, F., Köse, S.A., Aslantas, Y., Türker, Y. & Ozhan, H. (2012). Effect of combined oral contraceptive use on platelet volume in women at reproductive age. Clinical and Experimental Obstetrics & Gynecology, 39(3), 314-316.
  28. Abdalla, T.M., Kordofani, A.A.Y. & Nimir, A.A.H. (2008). Haemostatic studies in Sudanese women on oral contraceptive pills. Khartoum Medical Journal, 3, 116-118.
  29. Uloma, B., Elvis-Offiah, E., Bafor, E., Gerald, I. E., Osamwonyi, I, Viegelmann, C. & RuAngelie, E. (2016). In vivo investigation of female reproductive functions and parameters in nonpregnant mice models and mass spectrometric analysis of the methanol leaf extract of Emilia Coccinea (Sims) G Dons. Physiology and Reproduction, 4 (23), e13047.

Corresponding Author

Egbunah, M. O

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Phone: +234-802-818-9000